Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

38 results about "Dimethyl isosorbide" patented technology

Dimethyl Isosorbide. CAS No.: 5306-85-4. Dimethyl Isosorbide (DMI) is a high purity solvent and carrier which offers a safe, effective delivery enhancement mechanism for active ingredients in personal care products.

Sweat-resistant leather and preparation method thereof

The invention discloses sweat-resistant leather and a preparation method thereof. The sweat-resistant leather comprises a leather base layer, a bonding layer, a sweat-resistant layer and a silica gelsurface layer which are connected in sequence, and the sweat-resistant layer is prepared from the following components: leather powder, a treating agent, acrylic resin, cotton powder or fiber powder,hydrated aluminum chloride, cyclohexasiloxane, dimethyl isosorbide, an adhesive and a solvent. The preparation method of the sweat-resistant leather comprises the following steps: adding the acrylic resin and the treating agent into the leather powder, performing uniform mixing under stirring, and allowing the mixed material to stand for a period of time to obtain a first intermediate product; adding the cotton powder or the fiber powder, the hydrated aluminum chloride, the cyclohexasiloxane, the dimethyl isosorbide, the adhesive and the solvent into the first intermediate product, performinguniform stirring, and performing drying for a period of time to obtain a second intermediate product; pressing the second intermediate product to obtain the sweat-resistant layer; bonding the sweat-resistant layer to one surface of the leather layer through an adhesive; and coating the surface of the sweat-resistant layer by silica gel, and performing drying to obtain the silica gel layer. The sweat-resistant leather provided by the invention can prevent stink caused by sweat.
Owner:漳州香洲皮革有限公司

Quick-drying water-based anti-rust agent and preparation method thereof

The invention discloses a quick-drying water-based anti-rust agent which is characterized by being prepared from the following components in parts by weight: 3-5 parts of silicone-acrylic emulsion, 3-5 parts of vinyl acetate-acrylic emulsion, 1-2 parts of xanthan gum, 1-2 parts of dimethyl isosorbide, 1-2 parts of sulfonated caster oil, 0.3-0.5 part of succinic acid, 0.5-1 part of sodium dodecyl benzene sulfonate, 0.2-0.4 part of ethylene glycol monobutyl ether, 1-2 parts of petroleum sodium sulfonate, 3-5 parts of hydroxypropyl methyl cellulose, 1-2 parts of sodium silicate, 0.5-1 part of sodium polyacrylate, 4-6 parts of a modifying additive and 30-40 parts of water. The anti-rust agent can quickly form a hard and tough protection film on the metal surface, and is anti-fouling, anti-static, good in corrosion resistance and high temperature resistance and long in protection time.
Owner:HEFEI DAAN PRINTING

Bitterness aversion preparation and preparation method thereof, and anti-bite pen

The present invention discloses a bitterness aversion preparation. The bitterness aversion preparation comprises 85-90 parts of a carrier solvent, 3-4 parts of a bitter substance and 8-12 parts of anadditive. A preparation method of the bitterness aversion preparation comprises the following steps: (1) dissolving dimethyl isosorbide in ethyl acetate in proportion and conducting even stirring to obtain a solution A; (2) adding isopropanol to the solution A and conducting stirring and mixing to obtain a solution B; (3) adding the bitter substance into the solution B, conducting stirring until the bitter substance is completely dissolved, then adding an acrylic acid (acrylate) /methyl methacrylate copolymer, and conducting sealed stirring to obtain a solution C; and (4) adding a pomelo fruitextract while stirring to the solution C, and conducting even mixing to obtain the bitterness aversion preparation. An anti-bite pen is provided with a water absorbent cotton pen core and the bitterness aversion preparation is filled into the water absorbent cotton pen core. The bitterness aversion preparation, the preparation method thereof, and the anti-bite pen disclosed by the invention havethe following beneficial effects: 1, a bitterness effect is good; and 2, cross-contamination is not caused.
Owner:瑞雅科医药(北京)有限公司

Acne removing, skin tendering and whitening essence and preparation method thereof

The invention discloses acne removing, skin tendering and whitening essence and a preparation method thereof, and relates to the technical field of cosmetics. The essence comprises the following components in percentage by weight of a phase A including 0.05-0.1% of EDTA disodium, 0.15-0.4% of hydrolyzed sclerotium gum, 0.15-0.25% of xanthan gum, 0.2-1% of allantoin, 0.1-1% of methylparaben, 5-10%of glycerol, 5-8% of butanediol and 0.005-0.1% of polyquaternium-73; a phase B including 1-3% of carnosine, 2-4% of nicotinamide, 1-5% of acetylchitosamine, 2-6% of alpha-arbutin and 0.04-0.2% of sodium hyaluronate; and a phase C including 1-4% of dimethyl isosorbide, 0.3-1% of phenoxyethanol, 0.005-1% of essence and 82-100% of water. According to the acne removing, skin tendering and whitening essence and the preparation method thereof, acne-removing and skin-whitening essence cream is prepared through reasonable use and matching of various components and a special process; the synergistic effect among the components is very outstanding; the acne-removing and skin-whitening essence cream not only can efficiently inhibit formation of melanin to achieve an excellent whitening effect, but also has the prominent blackhead-removing, acne-removing and anti-inflammatory effects to achieve the skin-whitening and acne-removing effects of comprehensive conditioning; and the essence has advantages of simple preparation process, easiness in control and easiness in operation.
Owner:清远市华宝生物科技有限公司

Novel parenteral controlled release formulations of nsaid's

InactiveUS20130136798A1Avoiding associated adverse drug reactionEase patient painBiocideOrganic active ingredientsImmediate releaseAceclofenac
A controlled release parenteral formulation for treatment of pain and inflammation is provided. The formulation includes an effective amount of: one or more active drug moiety. The drug moiety is selected from a group comprising aceclofenac or diclofenac or a combination thereof; One or more solvent moiety selected from a group comprising one or more of ethyl acetate, triacetin, di methyl iso sorbide, DMA, DMSO, PEG, PVP, PVA, Span 80, DCM, Benzyl alcohol, acetone or a combination thereof. The formulation, upon administration, has a release profile including an immediate burst release and the burst release is followed by a slow release of at least 18 to 24 hrs. The immediate burst release and the slow release of the drug moiety remains within the therapeutic window of the drug moiety.
Owner:CHAUDHARY MANU
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products